Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karun Saathveeg Sam

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|March 14, 2024
Unilateral skin eruptionsKarun Saathveeg Sam, Pooja Khosla, Vinus Taneja, et al.
Communications Medicine|June 1, 2024
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case reportKarun Saathveeg Sam, Pooja Khosla, Vinus Taneja, et al.
BMJ Case Reports|February 25, 2026
Monoallelic PARN mutation presenting as pancytopenia, hepatic fibrosis and idiopathic pulmonary fibrosisJinal Soni, Karun Saathveeg Sam, Vinus Taneja, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|March 14, 2024
Unilateral skin eruptionsKarun Saathveeg Sam, Pooja Khosla, Vinus Taneja, et al.
Communications Medicine|June 1, 2024
Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case reportKarun Saathveeg Sam, Pooja Khosla, Vinus Taneja, et al.
BMJ Case Reports|February 25, 2026
Monoallelic PARN mutation presenting as pancytopenia, hepatic fibrosis and idiopathic pulmonary fibrosisJinal Soni, Karun Saathveeg Sam, Vinus Taneja, et al.
Pageof 1